Name: | Repligen |
---|---|
Link: | http://www.repligen.com/ |
Description: | Developing enabling technology for the discovery of new drugs. Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. A number of drug development programs are currently being conducted to evaluate our naturally occurring drug candidates in diseases such as schizophrenia, obsessive-compulsive disorder, bipolar disorder and neurodegeneration. |
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology education - National biotechnology education centre
Science Blogs - Blogs about science: Medicine, Biology, Physical science, ...
Gene-edited cells could halt multiple sclerosis progression
Tea brews up silver nanoparticles for wound healing in the developing world